Burcon posts Q1 loss as company cites ongoing commercialization, scale-up efforts and funding needs

Reuters2026/08/12 23:09

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

For the three months ended June 30, 2026, net loss widened to CAD 3.8 million from CAD 3.5 million.
Operating cash outflow improved to CAD 2.4 million from CAD 2.7 million, despite continued losses.
Accumulated deficit reached CAD 168.3 million; working capital remained negative at CAD 11.2 million.
Commercial production and sales continued at its Protein Production Facility for pea, canola, and fava proteins.
Solatein sunflower protein stayed at pilot scale; commercialization at the facility targeted for calendar 2027.
Liquidity actions included a CAD 1.4 million loan received subsequent to quarter-end; convertible notes offering launched for up to CAD 8.1 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Burcon NutraScience Corporation published the original content used to generate this news brief on August 12, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Burcon posts Q1 loss as company cites ongoing commercialization, scale-up efforts and funding needs

You may also like

Crypto prices